Divalproex Sodium Tablet, Extended Release
Product Images NDC 70518-3477

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-3477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a prescription drug named Divalproex Sodium. It comes in the form of an Extended-Release 500mg Tablet. It is manufactured by Lupin Pharma located in Baltimore, MD 21202. The NDC# of the source medication is 68180-0261-02 and has been repackaged by RemedyRepack Inc. located in Indiana, PA. The medication should be stored in a temperature range of 15-30°C (59-86°F). The package insert contains the directions for use. The product comes in a bottle containing 30 tablets. The expiry date and lot number are not visible. It should be kept out of the reach of children.*

FDA Label Image

Image 1 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 01)

FDA Label Image

Image 2 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 02)

The text seems to be a graph showing the percentage reduction in CPS (cycles per second) rate for patients taking Divalproex Sodium Delayed-Release compared to placebo. The graph also shows the percentage of patients who experienced improvement, no change, or worsening.*

FDA Label Image

Image 3 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 03)

FDA Label Image

Image 4 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.